Wai Chun Bio-Technology Limited (HKG:0660)

Wai Chun Bio-Technology Ratios and Metrics

Market cap in millions HKD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 21, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15	21	17	67	94	134
Market Cap Growth	-54.17%	22.55%	-73.98%	-28.57%	-29.96%	-77.50%
Enterprise Value	147	148	152	219	232	254
Last Close Price	0.09	0.13	0.10	0.40	0.56	0.81
PS Ratio	0.05	0.06	0.02	0.10	0.19	0.24
PB Ratio	-0.22	-0.39	1.66	11.14	-3.96	-10.36
P/FCF Ratio	1.31	1.78	0.84	-	-	-
P/OCF Ratio	0.56	0.41	0.36	21.10	-	-
EV/Sales Ratio	0.43	0.40	0.20	0.33	0.47	0.45
EV/EBITDA Ratio	33.73	22.99	7.10	8.97	30.22	13.30
EV/EBIT Ratio	-	-	12.78	12.18	142.65	18.11
EV/FCF Ratio	12.56	12.30	7.35	-	-	-
Debt / Equity Ratio	-2.13	-2.46	12.75	25.06	-6.20	-10.01
Debt / EBITDA Ratio	33.77	15.69	5.17	5.25	12.36	6.37
Debt / FCF Ratio	12.58	11.28	6.49	-	-	-
Asset Turnover	1.53	1.65	3.16	-	2.64	3.11
Inventory Turnover	10.34	4.83	8.34	-	7.71	8.07
Quick Ratio	0.27	0.13	0.31	0.33	0.29	0.13
Current Ratio	0.39	0.45	0.81	0.86	0.60	0.60
Return on Equity (ROE)	-	-	-121.40%	-	-	-
Return on Assets (ROA)	-2.67%	-0.75%	3.04%	-	0.54%	4.80%
Return on Capital (ROIC)	-5.22%	-1.49%	4.93%	-	0.84%	9.75%
Return on Capital Employed (ROCE)	-	-	14.60%	25.10%	5.40%	36.50%
Earnings Yield	-333.18%	-206.27%	-88.24%	-21.36%	-18.09%	-6.06%
FCF Yield	76.09%	56.20%	118.42%	-11.91%	-10.31%	-9.64%
Buyback Yield / Dilution	-1.51%	-1.51%	-0.78%	-0.14%	-0.90%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.